CG Oncology, Inc.
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -60.20M | -41.31M | -43.81M | -41.43M | -34.45M |
| Total Depreciation and Amortization | 841.00K | 849.00K | 416.00K | 156.00K | 24.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.20M | 8.23M | 7.37M | 4.65M | 4.68M |
| Change in Net Operating Assets | -5.78M | -3.98M | -2.87M | 8.66M | 469.00K |
| Cash from Operations | -56.94M | -36.22M | -38.89M | -27.96M | -29.28M |
| Capital Expenditure | -304.00K | -7.00K | -97.00K | -14.00K | -16.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | -21.97M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -334.54M | -75.50M | 37.11M | 1.42M | -186.75M |
| Cash from Investing | -334.85M | -75.51M | 15.05M | 1.41M | -186.77M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 393.22M | 99.11M | 54.10M | 19.00K | 682.00K |
| Repurchase of Common Stock | -174.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -47.00K | -39.00K | 270.00K | -315.00K | -232.00K |
| Cash from Financing | 393.00M | 99.07M | 54.37M | -296.00K | 450.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.21M | -12.66M | 30.52M | -26.85M | -215.60M |